When comparing MPN and sAML we observed that expression of TGF-β regulatory proteins like THBS1, LRRC32 and LTBP1 was downregulated and expression of TGF-β signaling inhibitors, like PEG10, was upregulated in sAML patients. The gene discussed is THBS1; the disease is myeloproliferative disorder.